SCHEMBL3755582

SCHEMBL3755582

CCc1ccc(OP(=O)(Cl)Cl)cc1

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 3/20 0.61
CYP2C19 P33261 1/20 0.61
POLB P06746 1/20 0.44
MAPT P10636 2/20 0.41
ALDH1A1 P00352 2/20 0.41
LMNA P02545 1/20 0.41
HPGD P15428 1/20 0.41
RXRA P19793 1/20 0.40
RXRB P28702 1/20 0.40
BLM P54132 1/20 0.39
MAPK1 P28482 1/20 0.39
CYP3A4 P08684 1/20 0.39
TSHR P16473 1/20 0.39
PLK1 P53350 1/20 0.38
MGLL Q99685 1/20 0.38
SRC P12931 1/20 0.38
TDP1 Q9NUW8 1/20 0.38
L3MBTL1 Q9Y468 1/20 0.38
RAB9A P51151 1/20 0.38
SOD1 P00441 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11511370 0.88 SMN1; SMN2 (0.61) SMN1; SMN2CYP2C19POLBMAPTALDH1A1
SCHEMBL5852173 0.86 SMN1; SMN2 (0.70) SMN1; SMN2CYP2C19POLBMAPTALDH1A1
SCHEMBL3758445 0.84 THRB (0.46) SMN1; SMN2CYP2C19POLBMAPTALDH1A1
SCHEMBL1413702 0.83 SMN1; SMN2 (0.66) SMN1; SMN2CYP2C19POLBMAPTALDH1A1
SCHEMBL10015246 0.82 MEN1 (0.48) SMN1; SMN2CYP2C19HPGDBLMCYP3A4
SCHEMBL11510266 0.81 CYP2C19 (0.54) SMN1; SMN2CYP2C19POLBMAPTLMNA
SCHEMBL778838 0.81 SMN1; SMN2 (0.69) SMN1; SMN2CYP2C19POLBMAPTALDH1A1
SCHEMBL3755586 0.80 SMN1; SMN2 (0.58) SMN1; SMN2CYP2C19POLBMAPTALDH1A1
SCHEMBL778578 0.79 SMN1; SMN2 (0.61) SMN1; SMN2CYP2C19POLBMAPTALDH1A1
SCHEMBL1101448 0.79 CYP2C19 (0.72) SMN1; SMN2CYP2C19POLBALDH1A1RXRA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-107573375-B A kind of Memantine derivative and preparation method thereof 成都苑东生物制药股份有限公司 2019-07-26 CN disclosed
CN-107573375-A A kind of Memantine derivative and preparation method thereof 成都苑东生物制药股份有限公司 2018-01-12 CN disclosed
US-20100298506-A1 METHOD FOR PRODUCING AN AMINO GROUP-CONTAINING PHOSPHATE COMPOUND, AND A FLAME-RETARDANT RESIN AND FLAME-RETARDANT RESIN COMPOSITION SHOWA HIGHPOLYMER CO., LTD. (JP) 2010-11-25 US disclosed
CN-101617014-A Flame-retardant adhesive composition, flexible copper-clad laminate and coverlay film SHOWA HIGHPOLYMER 2009-12-30 CN disclosed
CN-101460511-A Method for producing amino group-containing phosphate ester compound, flame-retardant resin, and flame-retardant resin composition SHOWA HIGHPOLYMER (JP) 2009-06-17 CN disclosed
EP-2036911-A1 PROCESS FOR PRODUCTION OF AMINATED PHOSPHORIC ACID ESTER COMPOUND, FLAME-RETARDANT RESIN, AND FLAME-RETARDANT RESIN COMPOSITION SHOWA HIGHPOLYMER CO., LTD. (JP) 2009-03-18 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100298506-A1 METHOD FOR PRODUCING AN AMINO GROUP-CONTAINING PHOSPHATE COMPOUND, AND A FLAME-RETARDANT RESIN AND FLAME-RETARDANT RESIN COMPOSITION ATIC, GART, RPP30 SMN1; SMN2 4067/4885CYP2C19 2840/4885POLB 924/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.